MannKind Announces Partnership With Type 1 Diabetes IndyCar Driver Conor Daly
May 13 2021 - 9:00AM
MannKind Corporation (Nasdaq: MNKD) is revved up to announce an
elevated partnership for the 2021 season with NTT INDYCAR SERIES
driver Conor Daly, who is living with Type 1 diabetes (T1D) and
will help raise awareness about diabetes and innovative management
options. MannKind will also be a primary sponsor for Ed Carpenter
Racing as Daly debuts the No. 20 MannKind Chevrolet at the May 15th
running of the GMR Grand Prix at Indianapolis Motor Speedway.
“MannKind first met Conor in early 2019, and his ability to rise
above any challenge he’s faced really resonates with us,” said
Michael Castagna, CEO of MannKind Corporation. “We are driven to
find new ways to give people control of their health, and Conor
exemplifies the very spirit of MannKind’s mission – living life
without limits.”
Daly was first diagnosed with diabetes at the age of 14, and
today is the only known U.S. professional racing driver who
competes full-time while living with T1D. “I’m excited to work with
MannKind again for the 2021 racing season and I look forward to
sharing my T1D story through this partnership,” said Daly. “I can’t
wait to get the No. 20 MannKind Chevrolet on the track this
weekend.”
The No. 20 MannKind Chevrolet will feature an edgy “Tired of
Pricks?” tagline –a purposeful wordplay designed to draw attention
to NeedleFreeInsulin.com. To highlight the text, the car presents
in a color scheme of magenta and teal which derives from MannKind’s
brand palette.
“We’re thrilled to introduce this head-turning livery when Conor
represents Ed Carpenter Racing this weekend at the Indianapolis
Motor Speedway,” said Alejandro Galindo, Chief Commercial Officer
of MannKind Corporation. “As part of an extended marketing
partnership, we will work closely with Daly on a series of
appearances to stress that living with diabetes should not stop you
from fully living your dreams. The first event is being planned for
the week of Indy 500 in late May.”
Like many professional racers, Daly started regularly competing
in karting at the age of 10. Four years later, he encountered a
hurdle when he found himself heading to the hospital having lost
weight and possessing an insatiable thirst for water. “I ended up
not racing that day, but rather had tests run to learn what was
going on with me,” recalled Daly. That answer came in the form of a
Type 1 diabetes diagnosis.
“It came as a surprise, but I knew that this was just another
challenge life was presenting, and I wasn’t going to let it slow me
down,” said Daly. True to his conviction, less than a week later he
was back racing at the go-kart track and went on to take home the
2006 World Karting Association Grand Nationals title. He progressed
to car racing in 2007, and has continued to thrive in the sport he
loves.
After finding success in both United States and international
open-wheel ladder systems, Daly made the decision to concentrate
solely on American motorsports in 2015. Over the past seven years,
he has competed in over 60 Indy car races. The 2021 NTT INDYCAR
SERIES season is Daly's second with ECR. He will compete for ECR in
14 of 17 events this year, driving the No. 20 Chevrolet during the
road and street course events. When ECR team owner Ed Carpenter
steps back into the No. 20 for the Indianapolis 500 later this
month, Daly will shift over to the No. 47 U.S. Air Force Chevrolet.
Known for a desire to sharpen his skills by racing in different
disciplines, Daly has recently competed in USAC Midgets,
Lamborghini Super Trofeo North America and NASCAR Camping World
Truck Series.
About MannKind CorporationMannKind Corporation
(Nasdaq: MNKD) focuses on the development and commercialization of
inhaled therapeutic products for patients with endocrine and orphan
lung diseases. MannKind is currently commercializing Afrezza®
(insulin human) Inhalation Powder, the Company’s first FDA-approved
product and the only inhaled ultra-rapid-acting mealtime insulin in
the United States, where it is available by prescription from
pharmacies nationwide. Afrezza is also available by prescription in
Brazil, where it is commercialized by the Company’s partner, Biomm
SA. MannKind was established in 1991, and is headquartered in
Westlake Village, Calif. with a manufacturing and R&D facility
based in Danbury, Conn. The Company also employs field sales and
medical representatives across the U.S. Please visit
mannkindcorp.com to learn more.
About Ed Carpenter RacingEd Carpenter Racing
(ECR) will be entering its 10th season of NTT INDYCAR SERIES
competition in 2021. The Indianapolis-based race team has proven
its versatility by collecting seven wins across each type of track
the series competes on – street and road courses, short ovals and
speedways. ECR is led by IndyCar’s only team owner/driver, Ed
Carpenter, three-time pole winner for the Indianapolis 500 (2013,
2014 and 2018). In 2021, Indiana natives Carpenter and Conor Daly
will share the No. 20 Chevrolet as Carpenter drives the oval races
and Daly takes over for the road and street course events. Both
will be entered in the Indianapolis 500 alongside 2020 Rookie of
the Year Rinus VeeKay, full-time driver of the No. 21 Chevrolet.
ECR made its eSports debut in the 2020 iRX World Championship with
Jim Beaver eSports. More information may be found at
http://www.edcarpenterracing.com/.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/928f9845-3312-499c-be77-e81fc0cb7e90
CONTACTS:
For MannKind:
Christie Iacangelo, Corporate Communications
(818) 292-3500
media@mannkindcorp.com
For Ed Carpenter Racing:
Brie Rentz, Communications Director
(765) 210-2646
brie.rentz@edcarpenterracing.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Aug 2024 to Sep 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Sep 2023 to Sep 2024